Recent selected publications supported by Schain Research
Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
Schain F et al. Transfus Apher Sci. March 2023.
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
Novitzky-Basso I et al. PLoS One. March 2023.
Treatment pattern characterization and outcomes in chronic graft versus host disease patients treated with extracorporeal photopheresis in clinical practise in Sweden
Schain F et al. Bone Marrow Transplant. March 2022.
Privacy preserving survival prediction
Fedeli S et al. Institue of Electrical and Electronics Engineers (IEEE) Big Data. January 2022.
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. Scand J Urol. June 2021.
HRU and sickness absence in newly diagnosed multiple myeloma patients who did not undergo HSCT: Trends in Sweden with the changing treatment landscape
Borgsten F et al. Eur J Hematol. May 2021.
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain F et al. Eur J Health Econ. March 2021.
Real-world data on autologous stem cell transplantation in older patients with multiple myeloma
Schain F et al. Annals of Hematology. December 2020.
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M et al. Scand J Urol. April 2020.
Survival outcomes in myelofibrosis patients treated with ruxolitinib: a population-based cohort study in Sweden and Norway
Schain F et al. European Journal of Haematology. December 2019.
Recent selected conference abstracts supported by Schain Research
Clinical Characterization and Healthcare Resource Utilization in Adrenoleukodystrophy: A Nationwide Retrospective Cohort Using Swedish National Registries
Jacob T et al. Value in Health. December 2023.
Correlation between overall survival and bladder-intact event-free survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden
Kwok KH et al. Annals of Oncology. October 2023.
Characteristics, treatment patterns and predictors of outcomes in treatment-naive acute myeloid leukemia patients judged ineligible for intensive chemotherapy in Sweden
Schain F et al. Myeloma and Leukemia. September 2021.
Healthcare resource utilization and sickness absence in newly diagnosed multiple myeloma patients in Sweden: Trends in a changing treatment landscape
Borgsten F et al. American Society of Hematology. December 2020.
Survival outcomes in patients with colorectal cancer in Sweden – A population based retrospective registry study
Pasquali L et al. Value in Health. December 2020.
Patient characterization and survival outcomes in pediatric chronic graft versus host disease patients: a population-based study in Sweden
Schain F et al. Bone Marrow Transplant. September 2020.
Real-world treatment patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. J Clin Oncol. May 2020.
Clinical outcomes and economic burden for bladder cancer patients: an analysis from a Swedish cancer registry
Bellmunt J et al. J Clin Oncol. April 2020.